Evidence map›Paper›PMID 42210404›Full record

ArticleTrials2026

Community-engaged participatory methods for embedding equity in trial design.

Martina Svobodova, Nina Jacob, Catherine Lamont Robinson, Becca Thomas, Harley Bryan, Jeremy Segrott, Sarah Bridges, Mashmooma Din, Allan Herbert, Islah Hamad and 4 more

Abstract read
In one paragraph

Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Martina SvobodovaCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK. svobodovam@cardiff.ac.uk.
Nina JacobCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Catherine Lamont RobinsonSocial and Community Medicine, Bristol Medical School, University of Bristol, Bristol, UK.
Becca ThomasCardiff University, Cardiff, UK.
Harley BryanCardiff University, Cardiff, UK.
Jeremy SegrottCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Sarah BridgesCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Mashmooma DinSouth Riverside Community Development Centre, Cardiff, UK.
Allan HerbertSouth Riverside Community Development Centre, Cardiff, UK.
Islah HamadCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Aysha H IliasCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Rena ZhangCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Sudipta BandyopadhyayCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.
Kense HayanCentre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCertain populations are consistently under-represented in randomised controlled trials (RCTs), including people from minority ethnic backgrounds and those experiencing socioeconomic disadvantage, language barriers, or marginalisation within health systems. This under-representation contributes to widening health inequities. While UK guidance such as the National Institute for Health and Care Research INCLUDE resources supports more inclusive research, practical methodologies for embedding equity in trial design remain limited. This paper draws on two linked public involvement projects: Talking Trials (2021-2023), working with ethnically diverse urban communities in Cardiff, and Let's Talk Research (2025), working with residents in a socioeconomically disadvantaged rural Welsh community.

methodsBoth projects used participatory methods including arts-based activities, deliberative dialogue, and co-production. Talking Trials incorporated thematic analysis of workshop reflections; both projects generated learning through reflective discussions with community partners.

resultsCommunity-based public contributors identified features that made research feel relevant and equitable: trusted relationships, time for dialogue, and support to understand complex concepts. Creative and dialogue-based approaches made research concepts accessible, reduced power imbalances, and supported contributors to move from unfamiliarity to active involvement. Sustained structures, such as advisory groups and community connectors, were important for maintaining trust and enabling continued engagement. Context strongly shaped involvement, with different forms of disadvantage requiring different types of support.

conclusionsCommunity-engaged, arts-based, and context-sensitive methods can meaningfully enhance equity in trial design. Embedding involvement early, investing in trusted partnerships, and sustaining long-term structures support more relevant, acceptable, and inclusive trials. These findings offer practical methodologies for trial teams seeking to embed equity from the outset.

Indexed as

Community-Based Participatory ResearchCommunity ParticipationHealth EquityPatient SelectionRandomized Controlled Trials as TopicResearch DesignDiversity, Equity, InclusionHumansMinority GroupsWales

Identifiers

PMID42210404
PMCPMC13411309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.